These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7184383

  • 1. [Antitumor effect of intraperitoneal administration of a streptococcal preparation, OK-432, in carcinomatous peritonitis. I. Experimental study in the rat].
    Saji S, Miya K, Oshita H, Nonomura O, Yokoyama Y, Yamamoto S, Takekoshi T, Sakata K.
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1961-8. PubMed ID: 7184383
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effect in peritoneal carcinomatosis of intraperitoneal administration of a streptococcal preparation, OK-432: I. Experimental study in the rat.
    Saji S, Umemoto T, Kida H, Sakata K.
    J Surg Oncol; 1985 Sep; 30(1):46-51. PubMed ID: 4079418
    [Abstract] [Full Text] [Related]

  • 3. [Intraperitoneal cavity injection of OK-432 with fresh human serum in a case of carcinomatous peritonitis--determination on the complement-derived chemotactic factor].
    Kato H, Kondo Y, Tanigawa M, Kin R, Sugino S, Kondo M.
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3251-5. PubMed ID: 3777961
    [Abstract] [Full Text] [Related]

  • 4. [The effect of intraperitoneal administration of OK-432 with recombinant interleukin-2 to patients with peritonitis carcinomatosa of recurrent gynecological cancer and changes in ascitic lymphocyte subsets].
    Kanaoka Y, Umesaki N.
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):489-96. PubMed ID: 2056223
    [Abstract] [Full Text] [Related]

  • 5. [Local immunotherapy for cancer].
    Hattori T, Niimoto M, Toge T, Hamamoto S, Seto Y, Kameda A, Tomoda S.
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1157-61. PubMed ID: 6503978
    [Abstract] [Full Text] [Related]

  • 6. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
    Hayashi Y, Torisu M.
    Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). I. Sequential effector mechanisms following a single OK-432 injection in F344 rats leading to the rejection of syngeneic MADB106 tumor cells.
    Fukui H, Reynolds CW.
    J Natl Cancer Inst; 1987 Nov; 79(5):1011-7. PubMed ID: 3479632
    [Abstract] [Full Text] [Related]

  • 8. [Intraperitoneal administration of OK-432 and rIL-2 in a case of peritonitis carcinomatosa with chronic renal failure].
    Kanaoka Y, Umesaki N, Kawabata M, Tsuda H, Sugawa T.
    Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):1027-31. PubMed ID: 2391442
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
    Mori H, Itoh N, Tamaya T.
    Immunopharmacol Immunotoxicol; 1989 May 20; 11(1):33-53. PubMed ID: 2503555
    [Abstract] [Full Text] [Related]

  • 10. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M, Yamamoto H, Mizoguchi T, Hidaka K, Hisatsugu T, Torisu M.
    Gan To Kagaku Ryoho; 1987 Aug 20; 14(8):2464-8. PubMed ID: 3497612
    [Abstract] [Full Text] [Related]

  • 11. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.
    Katano M, Torisu M.
    Surgery; 1983 Mar 20; 93(3):365-73. PubMed ID: 6600854
    [Abstract] [Full Text] [Related]

  • 12. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432.
    Watabe S, Sendo F, Kimura S, Arai S.
    J Natl Cancer Inst; 1984 Jun 20; 72(6):1365-70. PubMed ID: 6587156
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
    Fukui H, Reynolds CW.
    J Natl Cancer Inst; 1987 Nov 20; 79(5):1019-24. PubMed ID: 3500354
    [Abstract] [Full Text] [Related]

  • 14. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].
    Katano M, Mizoguchi T, Yamamoto H, Hisatsugu T, Torisu M.
    Nihon Geka Gakkai Zasshi; 1987 Dec 20; 88(12):1676-83. PubMed ID: 3447033
    [Abstract] [Full Text] [Related]

  • 15. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].
    Mukai M, Ando K, Koike S.
    Gan To Kagaku Ryoho; 1988 Apr 20; 15(4 Pt 1):631-5. PubMed ID: 3355184
    [Abstract] [Full Text] [Related]

  • 16. Adoptive immunotherapy in tumor-bearing mice with OK-432-induced killer cells.
    Ujiie T.
    Jpn J Exp Med; 1988 Apr 20; 58(2):109-14. PubMed ID: 3261814
    [Abstract] [Full Text] [Related]

  • 17. Effect of OK-432 on the lymphnode metastasis of MCA-sarcoma cell lines: a new therapeutic approach.
    Inoh A, Kodama Y, Yokoro K.
    Hiroshima J Med Sci; 1989 Dec 20; 38(4):213-9. PubMed ID: 2637250
    [Abstract] [Full Text] [Related]

  • 18. [Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432].
    Baba H, Tsujitani S, Korenaga D, Kakeji Y, Haraguchi M, Konoe S, Maehara Y, Sugimachi K.
    Gan To Kagaku Ryoho; 1990 Aug 20; 17(8 Pt 2):1596-9. PubMed ID: 2389954
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prophylactic therapy for liver metastasis of gastrointestinal carcinomas using biological response modifiers (BRM): fundamental studies on the inhibition of experimental liver metastasis by intraportal administration of OK-432].
    Kasagi T, Tazawa K, Yamashita I, Ishizawa S, Masuyama K, Fujimaki M, Maeda M.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan 20; 25(1):112-20. PubMed ID: 2324583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.